Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Central Admixture Pharmacy Services, Inc.
WARNING LETTER
•Central Admixture Pharmacy Services, Inc.•August 25, 2023

Central Admixture Pharmacy Services, Inc. – FDA Warning Letter, Aug 25, 2023

Record Details

The FDA issued a Warning Letter to Central Admixture Pharmacy Services Inc. (CAPS) San Diego, following an inspection from July 10 to August 25, 2023. The facility, registered as an outsourcing facility under section 503B of the FDCA, was de-registered as of October 17, 2023. The inspection revealed that drug products failed to meet 503B conditions and exhibited serious deficiencies in sterile drug production, posing patient risks.

Violations included misbranding due to inadequate labeling (e.g., missing established drug names for Ephedrine Sulfate, Fentanyl Citrate) and failure to submit adverse event reports. These failures render the compounded drugs ineligible for exemptions from FDA approval, adequate directions for use, and Drug Supply Chain Security Act requirements.

The facility's drug products were deemed adulterated under FDCA sections 501(a)(2)(A) and 501(a)(2)(B) due to insanitary conditions and CGMP violations. Insanitary conditions included inadequate product evaluation after microbial contamination in ISO 5 areas, improper gowning practices, insufficient material disinfection during transfer, and flawed surface sampling. CGMP violations encompassed failures in quality control unit procedures (21 CFR 211.22(d)), investigation of discrepancies (21 CFR 211.192), prevention of microbiological contamination (21 CFR

Company
Central Admixture Pharmacy Services, Inc.
Inspection date
August 25, 2023
Product type
Drugs
Office
Division of Pharmaceutical Quality Operations IV
People
  • Mariza Jafary
  • Jim West
  • Steven E. Porter (Program Division Director)
View Company Profile

ID · e499f627-97b3-4a36-bc43-b42bcde51710

Violation Codes10
21 U.S.C. 353b21.U.S.C. 355(a)21 U.S.C. 352(f)(1)21 U.S.C. 360eee-121 U.S.C. 353b(a)(10)21 U.S.C. 353b(b)(5)21 U.S.C. 353b(a)(1)21 U.S.C. 501(a)(2)(B)21 U.S.C. 501(a)(2)(A)21 CFR 210

Full citation text and observation details available on the Dashboard.

Other documents for Central Admixture Pharmacy Services, Inc.
  • WARNING_LETTER - 2023-07-31July 31, 2023
  • WARNING_LETTER - 2023-03-30March 30, 2023
  • 483 - 2015-12-04December 4, 2015
  • 483 - 2014-06-25June 25, 2014
  • 483 - 2013-02-22February 22, 2013

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Central Admixture Pharmacy Services, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.